EQT and Goldman Sachs completes Parexel acquisition

EQT Private Equity and Goldman Sachs have closed its previously announced buyout of Parexel, a global clinical research organization, for $8.5 billion.

17 November 2021•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles